Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Dec 1, 2025 9:00 AM ・ Updated Jun 13, 2026 11:48 PM ・ 2 min read ・ Source: PR Times
Sino-American Pharmaceutical Co., Ltd. (1734) reported its Q4 2025 financial results, with basic earnings per share (EPS) at NT$1.92. The company's revenue was NT$3.371 billion, and net profit after tax was NT$354 million.
Sino-American Pharmaceutical Co., Ltd. (Stock Code: 1734) announced its financial results for the fourth quarter of 2025. The company, operating in the biotechnology and healthcare industry, reported basic earnings per share (EPS) of NT$1.92. Revenue for the quarter stood at NT$3.371 billion, with a net profit after tax of NT$354 million.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.